Trial Profile
Relationship between sorafenib efficacy and decrease or disappearance of tumor stain on contrast enhanced CT images after 2 weeks treatment in advanced hepatocellular carcinoma (HCC) patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2017
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 08 Dec 2015 New trial record